Ian Frazer

Biography

 Leading cancer scientist and PM Science Prize winner, Professor Ian Frazer, was trained as a renal physician and clinical immunologist in Edinburgh, Scotland before emigrating in 1980 to Melbourne, Australia to pursue studies in viral immunology and autoimmunity at the Walter and Eliza Hall Institute of Medical Research with Professor Ian Mackay. In 1985 he moved north to Brisbane to take up a teaching post with the University of Queensland, and he now holds a personal chair as head of the Centre for Immunology and Cancer Research, a research institute of the University at the Princess Alexandra Hospital. His current research interests include immunoregulation, and immunotherapeutic vaccines for Papillomavirus associated cancers. As a one of Australia’s best known cancer scientists, Professor Frazer holds research funding from several Australian and US funding bodies. He is a director of a biotechnology start up company, Coridon, with an interest in optimising and targeting polynucleotide vaccine protein expression. He won the 2005 CSIRO Eureka Prize for Leadership in Science and was named Australian of the Year in 2006 for his development of the human papillomavirus (HPV) cervical cancer vaccines. Professor Frazer was appointed Chair of the Australian Cancer Research Foundation’s prestigious Medical Research Advisory Committee in 2009. The MRAC comprises a group of highly esteemed cancer scientists from all over Australia, working in collaboration to advise the ACRF of the most promising cancer research initiatives in the country.

Research Interest

 Clinical & Experimental Oncology Insights in Gynecologic Oncology  HPV and Cervical Cancer